EP Biocomposites Ltd. - Research Center

---

Results

• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

1.68

1.18

0.05

0.05

Share application money

-

-

-

-

Preference share capital

-

-

-

-

Reserves & surplus

6.73

0.82

0.34

-0.02

Loan funds

Secured loans

1.28

4.11

-

-

Unsecured loans

-

-

-

-

Total

9.70

6.11

0.39

0.03

Uses of funds

Fixed assets

Gross block

0.39

0.44

-

-

Less : revaluation reserve

-

-

-

-

Less : accumulated depreciation

0.05

0.03

-

-

Net block

0.33

0.41

-

-

Capital work-in-progress

-

-

-

-

Investments

-

-

-

-

Net current assets

Current assets, loans & advances

11.39

8.87

1.32

0.55

Less : current liabilities & provisions

2.03

3.17

0.94

0.52

Total net current assets

9.36

5.70

0.38

0.03

Miscellaneous expenses not written

-

-

-

-

Total

9.70

6.11

0.39

0.03

Notes:

Book value of unquoted investments

-

-

-

-

Market value of quoted investments

-

-

-

-

Contingent liabilities

-

-

-

-

Number of equity sharesoutstanding (Lacs)

16.82

11.78

0.50

0.50